Click the title above for a link to open the Applied Clinical Trials July/August 2024 issue in an interactive PDF format.
Applied Clinical Trials-08-01-2024
No longer "down the road" in their emergence, this issue of Applied Clinical Trials takes a deep look at the impact of decentralized clinical trials to date—and how their future trajectory could shape out.
A use case by Memorial Sloan Kettering Cancer Center explores the potential of EHR-to-EDC.
Five industry leaders share their perspectives on the evolution of DCTs.
Tracking efforts to advance the mission and concept of "clinical research as a care option."
Q&A with Joachim Lövin explores the challenges and lessons learned in boosting the flexibility of conducting decentralized clinical trials post-COVID.
Four strategies for implementing this approach in clinical trial staff and site training.
Minimizing protocol deviations is a simple, yet effective way for sites to keep trials patient-centric.
Site and project management teams play major roles in risk-management and monitoring performance.
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Phase IV Trial Shows Daybue Demonstrates Real-World Behavioral Improvements in Rett Syndrome
2
Merck Reports Strong Phase II Results for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
3
ACT Brief Weekly Recap: How AI, eClinical Innovation, and Policy Shifts Are Reshaping Clinical Research
4
Capvaxive Demonstrates Robust Immune Responses in Children, Adolescents at Increased Risk of Pneumococcal Disease
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
